How to Buy Abeona Therapeutics Stock
Abeona Therapeutics Inc
Abeona Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases.
Abeona Therapeutics stock last closed at $4.00, down 0.74% from the previous day, and has increased 1.47% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Abeona Therapeutics stock is currently +82.65% from its 52-week low of $2.19, and -34.75% from its 52-week high of $6.13.
There are currently 18.78M shares of ABEO outstanding. The market cap of ABEO is $75.11M. In the last 24 hours, 202,898 ABEO shares were traded.
How to Buy Abeona Therapeutics Stock
Not sure how to invest in Abeona Therapeutics stock? Here's how.
- Decide where to buy Abeona Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Abeona Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your method of payment and add your details.
- Analyze Abeona Therapeutics stock: The Abeona Therapeutics ticker symbol is ABEO. Is Abeona Therapeutics stock a good investment? Should you buy shares of ABEO? How do ABEO's underlying business fundamentals look? Do top analysts think Abeona Therapeutics is a good buy? Why has ABEO's stock price moved recently? (Hint: Our stock analysis website can help you understand if ABEO is a good stock to buy).
- Make your ABEO trade: Decide if you will purchase ABEO shares at the current market price or use a limit order to purchase ABEO shares at a given price.
- Keep an eye on your ABEO investment: Create a watchlist to the latest updates on your new investment in Abeona Therapeutics shares.
Step 1: Decide where to buy Abeona Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy ABEO stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal info so you are able to invest in ABEO stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.
- Input your personal data to create your new brokerage account.
- Send your details by hitting the "Create Account" button.
Step 3: Put funds into your brokerage account
Now that you've opened your account on the best investment app, your next step is to transfer the money for your investment:
Watch the walkthrough below for more details transferring funds into your brokerage account.
Step 4: Analyze Abeona Therapeutics stock
Once you have selected the best place to buy Abeona Therapeutics stock, it's crucial to research their stock prior to investing, so you can understand the risk as well as the upside.
Abeona Therapeutics quick stats
Abeona Therapeutics Due Diligence Checks
WallStreetZen was designed to help average investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on ABEO's stock page.
What is the fair value of ABEO stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ABEO's intrinsic value.
Using relative valuations metrics:
- ABEO could be undervalued based on its P/B ratio of 4.01x, relative to Biotechnology industry P/B ratio of 5.27x
You can do additional valuation analysis on ABEO's stock here.
How do ABEO Financials look?
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the ABEO balance sheet.
- ABEO has $40.70M in cash and short term investments. This is enough to cover its annual cash burn of $40.05M.
- ABEO has cash burn of 40051000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the ABEO balance sheet.
Negative Financial Indicators:
- Total ABEO debt is higher than 5 years ago, relative to shareholder equity.
- ABEO profit margin has gone down from -2,719% to -2,977% in the past year.
- ABEO has a relatively high debt to equity ratio of 1.85.
Is ABEO stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 sell side analysts who monitor ABEO, the consensus analyst rating on ABEO is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest ABEO Analyst Recommendations
James Molloy, a bottom 2% analyst from Alliance Global Partners reiterates ABEO with a strong buy rating and maintains their ABEO price target from $20.00 to $20.00, on May 24, 2023.
You can dive deeper into what analysts are projecting on the Abeona Therapeutics stock forecast page.
ABEO Technical Indicators
Is ABEO Making Money?
Last year, ABEO revenue was $1.07M. In the last 5 year, ABEO's revenue has increased by -2.01% per year. This was slower than the Biotechnology industry average of 89.9%.
Learn more about ABEO's earnings and revenue performance here.
What are ABEO executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at ABEO have sold more shares than they have bought.
Vishwas Seshadri, Chief Executive Officer of ABEO, was the latest ABEO insider to sell. They sold $2,530.62 worth of ABEO stock on Jun 2, 2023.
Learn more about who owns ABEO stock here.
Can I rely on ABEO as an income stream?
No, Abeona Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about ABEO?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your ABEO trade
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount limit, use a limit order.
Click the Open button and your broker will execute your order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your ABEO investment
Now that you own some ABEO stock, you'll want to keep up with your shares.
Put ABEO on a watchlist to monitor your ABEO stock.
ABEO Feed
How to Buy Stock in Abeona Therapeutics
To reiterate, here are the 6 steps for buying Abeona Therapeutics stock:
- Decide where to buy Abeona Therapeutics stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Analyze Abeona Therapeutics stock
- Make your ABEO trade
- Keep an eye on your ABEO investment
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your new investment in Abeona Therapeutics, hit the button below to create your watchlist.
Trending Articles
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.